Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Neurology · Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum

Symptoms and the Path of Progression

At a Glance

H-ABC often begins in infancy with developmental delay or unusual muscle tone and may progress to movement problems, feeding difficulties, or loss of learned skills. These are group patterns, so a child’s TUBB4A variant and clinical changes must be interpreted by the care team.

Every child with H-ABC follows a unique path, but understanding the common patterns of the condition can help you prepare for the future. H-ABC is a progressive disease, meaning its symptoms and their impact on daily life change over time [1]. While these changes can be challenging, knowing what to look for allows you to work closely with your medical team to manage symptoms as they arise. Keep in mind that group-level patterns observed in medical research do not determine or predict an individual child’s exact future.

Early Signs and the First Months

For most children with H-ABC, the first signs appear in infancy, often around 8 to 9 months of age [1]. You may first notice that your child is not reaching developmental milestones on the typical schedule. Common early symptoms include:

  • Developmental Delay: A lag in reaching expected milestones like rolling over, sitting up, or reaching for toys [1].
  • Tone Abnormalities: Your child’s muscles may feel unusually “floppy” (hypotonia) or, conversely, quite stiff [1].
  • Movement Issues: You might see early signs of unusual postures or movements [2].

Two Main Patterns of Progression

Doctors often look at when symptoms first appear and how quickly they progress to help understand the condition. These are group patterns, not strict subtypes.

Early-Infantile Form

This is generally a more severe presentation early on. Children in this cohort often do not sit independently by the age of 9 months [1]. They are more likely to face early challenges with:

  • Feeding and Swallowing: Difficulty managing food or liquids safely [1].
  • Seizures: This group has a higher prevalence of seizures compared to those with later-onset forms [1].
  • Orthopedic Issues: Complications like scoliosis (curvature of the spine) or hip dislocations occur earlier or more frequently [1].

Late-Infantile Form

In this pattern, children often meet their early milestones on time. They may learn to hold their head up, sit without support, and sometimes walk independently [3][1]. However, as the disease progresses, they may begin to lose these abilities—a process called developmental regression [3].

The Role of Genetic Variants

The specific pathogenic variant in the TUBB4A gene can provide clues to the clinical team, though genotype-phenotype correlations are not deterministic. One common variant, known as p.Asp249Asn (or D249N), has been heavily studied:

  • Initial Milestone Attainment: Children with this variant often reach peak motor and communication skills that are similar to other children with milder forms of H-ABC [1].
  • Functional Decline: Cohort studies observe that children with the D249N variant often experience a more rapid loss of functional abilities compared to children with other variants [1][3]. Researchers report many in this group lose the ability to walk during their first decade [2]. Your treating team will interpret your child’s specific variant in the context of their actual function.

Navigating Movement Disorders

As H-ABC progresses, movement becomes more complex. It is important to distinguish between different types of movement disorders:

  • Extrapyramidal Signs: These originate from the basal ganglia and include dystonia (involuntary muscle contractions causing twisting or repetitive movements), rigidity, chorea, and tremor [2][4].
  • Pyramidal Signs: These involve the corticospinal tracts and present primarily as spasticity (stiffness or tightness in the muscles) [5].
  • Ataxia: A lack of muscle coordination that can cause shakiness or trouble with balance and gait, stemming from cerebellar involvement [4][6].

While extrapyramidal signs might be absent in the very early stages, they often emerge and become more noticeable as the child grows [4]. Understanding that these changes are part of the disease’s natural progression can help you and your doctors adjust therapies and support systems to keep your child comfortable and engaged [7].

Common questions in this guide

At what age do H-ABC symptoms usually start?
For many children, the first signs appear in infancy, often around 8 to 9 months. Early clues can include delayed milestones, unusually floppy or stiff muscles, and unusual postures or movements, but timing varies.
What early developmental signs should I watch for in H-ABC?
A child may be slower to roll, sit, reach for toys, or achieve other expected milestones. Changes in muscle tone, such as hypotonia or stiffness, can also be early signs.
Can a child with H-ABC lose skills they already learned?
Yes. In some children, especially those with a later-infantile pattern, early milestones are reached before motor or communication abilities begin to decline; this loss is called developmental regression. The timing and degree of change vary from child to child.
What movement problems can develop as H-ABC progresses?
Children may develop dystonia, rigidity, chorea, or tremor from basal ganglia involvement, as well as spasticity or ataxia. These problems can appear or become more noticeable over time and may affect posture, coordination, balance, or walking.
Does a TUBB4A variant predict how my child’s H-ABC will progress?
A TUBB4A variant can give the clinical team useful context, but it cannot determine an individual child’s future on its own. The p.Asp249Asn (D249N) variant has been associated in groups with faster functional decline, so clinicians interpret it alongside the child’s actual abilities and changes.
When should feeding or swallowing problems be evaluated in H-ABC?
Evaluation is important if a child has trouble managing food or liquids, coughs or chokes during meals, or takes unusually long to eat. The care team may recommend a clinical or instrumental swallow study to assess safety and guide support.

Get notified when new evidence is published on Hypomyelination with atrophy of basal ganglia and cerebellum.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    The natural history of variable subtypes in pediatric-onset TUBB4A-related leukodystrophy.

    Gavazzi F, Charsar B, Hamilton E, et al.

    Molecular genetics and metabolism 2025; (144(3)):109048 doi:10.1016/j.ymgme.2025.109048.

    PMID: 39951964
  2. 2

    Therapeutic suppression of Tubb4a rescues H-ABC leukodystrophy.

    Sase S, Hacker JL, Napit PR, et al.

    Molecular therapy : the journal of the American Society of Gene Therapy 2026; (34(5)):2923-2943 doi:10.1016/j.ymthe.2026.01.016.

    PMID: 41566774
  3. 3

    Acquisition of Developmental Milestones in Hypomyelination With Atrophy of the Basal Ganglia and Cerebellum and Other TUBB4A-Related Leukoencephalopathy.

    Gavazzi F, Charsar BA, Williams C, et al.

    Journal of child neurology 2021; (36(10)):805-811 doi:10.1177/08830738211000977.

    PMID: 34514881
  4. 4

    TUBB4A-related hypomyelinating leukodystrophy: New insights from a series of 12 patients.

    Tonduti D, Aiello C, Renaldo F, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016; (20(2)):323-330 doi:10.1016/j.ejpn.2015.11.006.

    PMID: 26643067
  5. 5

    [A report of atypical hypomyelinating leukodystrophy with atrophy of the basal ganglia and cerebellum caused by a de novo mutation in tubulin beta 4A (TUBB4A) gene and literature review].

    Du Y, Li C, Guo J, et al.

    Zhonghua nei ke za zhi 2017; (56(6)):433-437 doi:10.3760/cma.j.issn.0578-1426.2017.06.009.

    PMID: 28592043
  6. 6

    Longitudinal Evaluation of Cerebellar Signs of H-ABC Tubulinopathy in a Patient and in the taiep Model.

    Alata M, González-Vega A, Piazza V, et al.

    Frontiers in neurology 2021; (12()):702039 doi:10.3389/fneur.2021.702039.

    PMID: 34335454
  7. 7

    POLR3-Related Leukodystrophy: A Qualitative Study on Parents' Experiences With the Health Care System.

    Le A, Thibault KA, Yazdani PA, et al.

    Pediatric neurology 2025; (166()):81-87 doi:10.1016/j.pediatrneurol.2025.02.011.

    PMID: 40106878

This page is for informational purposes only and does not constitute medical advice. It describes group patterns in H-ABC, but cannot predict an individual child’s course; discuss symptoms, changes, and feeding concerns with the child’s healthcare team.